Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma
Sequencing studies have deciphered the genetic landscape of primary central nervous system lymphoma (PCNSL) paving novel therapeutic avenues in recent years.1,2
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 April 2022
|
| In: |
Neuro-oncology advances
Year: 2022, Jahrgang: 4, Heft: 1, Pages: 1-4 |
| ISSN: | 2632-2498 |
| DOI: | 10.1093/noajnl/vdac051 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1093/noajnl/vdac051 Verlag, kostenfrei, Volltext: https://academic.oup.com/noa/article/4/1/vdac051/6568032 
|
| Verfasserangaben: | Leon D. Kaulen, Christoph Gumbinger, Felix Hinz, Tobias Kessler, Frank Winkler, Martin Bendszus, Felix Sahm, and Wolfgang Wick |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1806552620 | ||
| 003 | DE-627 | ||
| 005 | 20220820195810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220609s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/noajnl/vdac051 |2 doi | |
| 035 | |a (DE-627)1806552620 | ||
| 035 | |a (DE-599)KXP1806552620 | ||
| 035 | |a (OCoLC)1341461032 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Kaulen, Leon D. |d 1992- |e VerfasserIn |0 (DE-588)1234159724 |0 (DE-627)1759034819 |4 aut | |
| 245 | 1 | 0 | |a Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |c Leon D. Kaulen, Christoph Gumbinger, Felix Hinz, Tobias Kessler, Frank Winkler, Martin Bendszus, Felix Sahm, and Wolfgang Wick |
| 264 | 1 | |c 13 April 2022 | |
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.06.2022 | ||
| 520 | |a Sequencing studies have deciphered the genetic landscape of primary central nervous system lymphoma (PCNSL) paving novel therapeutic avenues in recent years.1,2 | ||
| 700 | 1 | |a Gumbinger, Christoph |e VerfasserIn |0 (DE-588)138155178 |0 (DE-627)696381117 |0 (DE-576)306183927 |4 aut | |
| 700 | 1 | |a Hinz, Felix |e VerfasserIn |4 aut | |
| 700 | 1 | |a Keßler, Tobias |d 1987- |e VerfasserIn |0 (DE-588)1104151693 |0 (DE-627)86164591X |0 (DE-576)470840277 |4 aut | |
| 700 | 1 | |a Winkler, Frank |d 1971- |e VerfasserIn |0 (DE-588)120794586 |0 (DE-627)704993104 |0 (DE-576)292388586 |4 aut | |
| 700 | 1 | |a Bendszus, Martin |e VerfasserIn |0 (DE-588)1032676426 |0 (DE-627)738634131 |0 (DE-576)175567697 |4 aut | |
| 700 | 1 | |a Sahm, Felix |d 1984- |e VerfasserIn |0 (DE-588)1022852132 |0 (DE-627)717318478 |0 (DE-576)366075020 |4 aut | |
| 700 | 1 | |a Wick, Wolfgang |d 1970- |e VerfasserIn |0 (DE-588)120297736 |0 (DE-627)080586929 |0 (DE-576)186221320 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuro-oncology advances |d Oxford : Oxford University Press, 2019 |g 4(2022), 1, Seite 1-4 |w (DE-627)1691023000 |w (DE-600)3009682-0 |x 2632-2498 |7 nnas |a Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| 773 | 1 | 8 | |g volume:4 |g year:2022 |g number:1 |g pages:1-4 |g extent:4 |a Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma |
| 856 | 4 | 0 | |u https://doi.org/10.1093/noajnl/vdac051 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://academic.oup.com/noa/article/4/1/vdac051/6568032 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220609 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 120297736 |a Wick, Wolfgang |m 120297736:Wick, Wolfgang |d 910000 |d 911100 |e 910000PW120297736 |e 911100PW120297736 |k 0/910000/ |k 1/910000/911100/ |p 8 |y j | ||
| 998 | |g 1022852132 |a Sahm, Felix |m 1022852132:Sahm, Felix |d 910000 |d 912000 |d 50000 |e 910000PS1022852132 |e 912000PS1022852132 |e 50000PS1022852132 |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 7 | ||
| 998 | |g 1032676426 |a Bendszus, Martin |m 1032676426:Bendszus, Martin |d 910000 |d 911100 |e 910000PB1032676426 |e 911100PB1032676426 |k 0/910000/ |k 1/910000/911100/ |p 6 | ||
| 998 | |g 120794586 |a Winkler, Frank |m 120794586:Winkler, Frank |d 910000 |d 911100 |e 910000PW120794586 |e 911100PW120794586 |k 0/910000/ |k 1/910000/911100/ |p 5 | ||
| 998 | |g 1104151693 |a Keßler, Tobias |m 1104151693:Keßler, Tobias |d 910000 |d 911100 |e 910000PK1104151693 |e 911100PK1104151693 |k 0/910000/ |k 1/910000/911100/ |p 4 | ||
| 998 | |g 138155178 |a Gumbinger, Christoph |m 138155178:Gumbinger, Christoph |d 910000 |d 911100 |d 50000 |e 910000PG138155178 |e 911100PG138155178 |e 50000PG138155178 |k 0/910000/ |k 1/910000/911100/ |k 0/50000/ |p 2 | ||
| 998 | |g 1234159724 |a Kaulen, Leon D. |m 1234159724:Kaulen, Leon D. |d 910000 |d 911100 |e 910000PK1234159724 |e 911100PK1234159724 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1806552620 |e 4146508398 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma","title_sort":"Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphoma"}],"name":{"displayForm":["Leon D. Kaulen, Christoph Gumbinger, Felix Hinz, Tobias Kessler, Frank Winkler, Martin Bendszus, Felix Sahm, and Wolfgang Wick"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"13 April 2022"}],"person":[{"family":"Kaulen","display":"Kaulen, Leon D.","role":"aut","given":"Leon D."},{"given":"Christoph","role":"aut","display":"Gumbinger, Christoph","family":"Gumbinger"},{"given":"Felix","role":"aut","display":"Hinz, Felix","family":"Hinz"},{"role":"aut","display":"Keßler, Tobias","family":"Keßler","given":"Tobias"},{"given":"Frank","role":"aut","display":"Winkler, Frank","family":"Winkler"},{"role":"aut","display":"Bendszus, Martin","family":"Bendszus","given":"Martin"},{"given":"Felix","family":"Sahm","role":"aut","display":"Sahm, Felix"},{"display":"Wick, Wolfgang","role":"aut","family":"Wick","given":"Wolfgang"}],"id":{"doi":["10.1093/noajnl/vdac051"],"eki":["1806552620"]},"note":["Gesehen am 09.06.2022"],"language":["eng"],"physDesc":[{"extent":"4 S."}],"recId":"1806552620","relHost":[{"pubHistory":["Volume 1, issue 1 (May/December 2019)-"],"language":["eng"],"origin":[{"dateIssuedDisp":"[2019]-","publisherPlace":"Oxford","publisher":"Oxford University Press"}],"id":{"issn":["2632-2498"],"eki":["1691023000"],"zdb":["3009682-0"]},"part":{"year":"2022","text":"4(2022), 1, Seite 1-4","pages":"1-4","issue":"1","extent":"4","volume":"4"},"disp":"Intraventricular immune checkpoint inhibition with nivolumab in relapsed primary central nervous system lymphomaNeuro-oncology advances","title":[{"title":"Neuro-oncology advances","title_sort":"Neuro-oncology advances","subtitle":"NOA"}],"name":{"displayForm":["Society for NeuroOncology ; European Association of Neuro-Oncology"]},"recId":"1691023000","note":["Gesehen am 27.08.2024"],"titleAlt":[{"title":"NOA"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}]} | ||
| SRT | |a KAULENLEONINTRAVENTR1320 | ||